Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

262 results
Display

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab

Ohshima Y, Kinoshita , Akita Y, Tamada Y, Watanabe D

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Long Term Case Series Study of the Effect of Omalizumab on Chronic Spontaneous Urticaria

Lefevre AC, Deleuran M, Vestergaard C

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cetuximab Related Eyelash Elongations for Patients with Metastatic Rectum Carcinoma: Metabolic Complete Response

Urun Y, Utkan G

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Vedolizumab, an alpha4beta7 Integrin Antibody, in Crohn's Disease and Ulcerative Colitis

Kim ES

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of Trough Serum Levels and Immunogenicity onLong-term Outcome of Adalimumab Therapy in Crohn's Disease(Gastroenterology 2009;137:1628-1640)

Seo GS

  • KMID: 2284969
  • Intest Res.
  • 2009 Dec;7(2):135-136.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer

Pujade-Lauraine E

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis

Kim JH, Cheon JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab

Agusti-Mejias A, Messeguer , Garcia R, Febrer I

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Golimumab Therapy in Ulcerative Colitis

Moon W

Ulcerative colitis is a chronic inflammatory condition of the colon, characterized by diffuse mucosal inflammation and blood-mixed diarrhea. The main treatment has been 5-aminosalicylic acid, steroid, thiopurine, and anti-tumor necrosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comprehensive Identification of Tumor-associated Antigens via Isolation of Human Monoclonal Antibodies that may be Therapeutic

Kurosawa Y

Although the success of trastuzumab and rituximab for treatment of breast cancer and non-Hodgkins lymphoma, respectively, suggests that monoclonal antibodies (mAbs) will become important therapeutic agents against a wider range...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New drugs for Rheumatoid arthritis

Seo YI

  • KMID: 2257380
  • Korean J Med.
  • 2009 Jan;76(1):12-17.
Since the late 1990s, based on scientific advancement and biotechnological improvement, many effective drugs such as leflunomide and biologic agents for rheumatoid arthritis (RA) have been developed. These include TNF-alpha...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Asthma Year in Review

Kim SH

  • KMID: 2319450
  • Tuberc Respir Dis.
  • 2010 Dec;69(6):411-417.
This review highlights articles pertaining to the following 5 topics: the relationship between asthma, allergic and non-allergic rhinitis; the novel asthma phenotypes using cluster analysis; the diagnostic properties of inhaled...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oral Immunotherapy for Food Allergy: Towards a New Horizon

Khoriaty E, Umetsu DT

Food allergy has increased dramatically in prevalence over the past decade in westernized countries, and is now a major public health problem. Unfortunately for patients with food allergy, there is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Granuloma Annulare Induced by Adalimumab

Oh YJ, Choi WJ, Ko JY, Ro YS

  • KMID: 2247582
  • Korean J Dermatol.
  • 2011 Jul;49(7):656-659.
Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-alpha) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-alpha...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Perspective: Role of Targeted Therapy in Colon Cancer

Chung HH, Jang BI

Colorectal cancer is the third most common malignant disease in incidence according to a report in 2009 from Korea. The 5-fluorouracil (5-FU) remains to be a major chemotherapeutic agents. But,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Psoriasiform Eruption Triggered by Tumor Necrosis Factor-alpha Antagonist Therapy

Choi YJ, Kim DS, Park JM, Oh SH, Park YK, Lee JH

  • KMID: 2248315
  • Korean J Dermatol.
  • 2008 May;46(5):721-723.
Tumor necrosis factor-alpha antagonists include monoclonal antibodies, infliximab, adalimumab, etanercept and golimumab. Clinical trials of these agents have shown that they are remarkably effective for psoriasis, but cutaneous adverse reactions...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recalcitrant Atopic Dermatitis Treated with Omalizumab

Park SY, Choi MR, Na JI, Youn SW, Park KC, Huh CH

Atopic dermatitis (AD) is a chronic cutaneous inflammatory disease. Various categories of therapeutic medications are used for treating AD. Omalizumab is a monoclonal anti-IgE antibody that binds to IgE molecules...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Psoriasiform Dermatitis Following Adalimumab Injection for Treatment of Ankylosing Spondylitis

Hahn HJ, Jung JW, Park HJ, Lee YW, Choe YB, Ahn KJ

  • KMID: 2246600
  • Korean J Dermatol.
  • 2013 Sep;51(9):743-745.
Adalimumab (Humira(TM)) is the first fully humanized monoclonal TNF-alpha antibody that antagonizes the effects of TNF-alpha. Its use has been found in the treatment of various rheumatologic disorders, namely rheumatoid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Psoriasis Induced by Trastuzumab (Herceptin(R))

Kim DH, Jeong NJ, Im M, Lee Y, Seo YJ, Lee JH

Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Rituximab Use in Rheumatoid Arthritis Following Anti-TNF-Associated Tuberculosis

Kim KH, Moon KW, Heo JW, Lee WH, Lee SH, Jeong CM, Park HS

Rituximab has been shown to be effective in rheumatoid arthritis (RA) and is recommended for patients exhibiting an inadequate response to tumor necrosis factor (TNF) inhibitors. To date, there have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr